NEW YORK, Aug. 7, 2020 /PRNewswire/ — Rosen Regulation Agency, a worldwide investor rights regulation agency, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between February 25, 2020 and Might 15, 2020, inclusive (the “Class Interval”), of the vital August 17, 2020 lead plaintiff deadline within the securities class motion. The lawsuit seeks to get better damages for Co-Diagnostics buyers beneath the federal securities legal guidelines.
To hitch the Co-Diagnostics class motion, go to http://www.rosenlegal.com/cases-register-1876.html or name Phillip Kim, Esq. toll-free at 866-767-3653 or e mail [email protected] or [email protected] for data on the category motion.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.
The Grievance alleges that defendants made continuous, figuring out and willful misstatements about their principal product, a COVID-19 diagnostic check, to pump up the value of Co-Diagnostics’ inventory whereas the officers and administrators exercised low priced choices and dumped their inventory into the market. Their fraudulent misstatements, and disrespect for the fundamental scientific ideas that make their falsity of their statements clear looking back, precipitated buyers to lose thousands and thousands of {dollars}. When the true particulars entered the market, the lawsuit claims that buyers suffered damages.
A category motion lawsuit has already been filed. In the event you want to function lead plaintiff, it’s essential to transfer the Court docket no later than August 17, 2020. A lead plaintiff is a consultant social gathering performing on behalf of different class members in directing the litigation. In the event you want to be part of the litigation, go to http://www.rosenlegal.com/cases-register-1876.html or to debate your rights or pursuits relating to this class motion, please contact Phillip Kim, Esq. of Rosen Regulation Agency toll free at 866-767-3653 or through e-mail at [email protected] or [email protected].
Observe us for updates on LinkedIn: https://www.linkedin.com/firm/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Fb: https://www.fb.com/rosenlawfirm/.
Rosen Regulation Agency represents buyers all through the globe, concentrating its follow in securities class actions and shareholder by-product litigation. Rosen Regulation Agency was Ranked No. 1 by ISS Securities Class Motion Providers for variety of securities class motion settlements in 2017. The agency has been ranked within the prime 3 annually since 2013. Rosen Regulation Agency has achieved the most important ever securities class motion settlement in opposition to a Chinese language Firm. Rosen Regulation Agency’s attorneys are ranked and acknowledged by quite a few unbiased and revered sources. Rosen Regulation Agency has secured a whole bunch of thousands and thousands of {dollars} for buyers. Legal professional Promoting. Prior outcomes don’t assure an analogous end result.
——————————-
Contact Data:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Regulation Agency, P.A.
275 Madison Avenue, fortieth Ground
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
View authentic content material to obtain multimedia:http://www.prnewswire.com/news-releases/rosen-nationally-regarded-investor-counsel-reminds-co-diagnostics-inc-investors-of-important-august-17-deadline-in-securities-class-action–codx-301108610.html
SOURCE Rosen Regulation Agency, P.A.